0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Research Report 2026
Published Date: 2026-01-23
|
Report Code: QYRE-Auto-18S9258
Home | Market Reports
Global Extracorporeal Membrane Oxygenation ECMO Systems Market Insights and Forecast to 2028
BUY CHAPTERS

Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Research Report 2026

Code: QYRE-Auto-18S9258
Report
2026-01-23
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size

The global Extracorporeal Membrane Oxygenation (ECMO) Systems market was valued at US$ 262 million in 2025 and is anticipated to reach US$ 337 million by 2032, at a CAGR of 3.7% from 2026 to 2032.

Extracorporeal Membrane Oxygenation (ECMO) Systems Market

Extracorporeal Membrane Oxygenation (ECMO) Systems Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Extracorporeal Membrane Oxygenation (ECMO) Systems competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
The Extracorporeal Membrane Oxygenation (ECMO) Systems market is primarily driven by the increasing incidence of severe respiratory and cardiac conditions, alongside advancements in critical care technologies. Conditions like acute respiratory distress syndrome (ARDS) and heart failure are on the rise, and ECMO systems provide crucial support in cases where traditional respiratory support like ventilators is insufficient. The COVID-19 pandemic further highlighted ECMO's life-saving potential, prompting healthcare providers and governments worldwide to invest in ECMO infrastructure, especially for high-acuity facilities. Additionally, advancements in ECMO technology, such as portable systems and improved oxygenators, have broadened their applicability and increased adoption in neonatal and pediatric intensive care settings, driving overall market growth.
However, the ECMO systems market faces significant challenges, particularly due to high equipment and procedural costs, which limit accessibility to larger, well-funded healthcare centers. ECMO also requires skilled professionals for operation and patient monitoring, a demand that current healthcare systems struggle to meet, especially in low- and middle-income countries. Regulatory constraints further add to the barriers, as ECMO systems undergo strict safety and efficacy evaluations that can delay market entry and increase costs for manufacturers. These challenges collectively hinder ECMO system adoption and accessibility, making it a critical yet resource-intensive technology in the healthcare industry.
This report delivers a comprehensive overview of the global Extracorporeal Membrane Oxygenation (ECMO) Systems market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracorporeal Membrane Oxygenation (ECMO) Systems. The Extracorporeal Membrane Oxygenation (ECMO) Systems market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Extracorporeal Membrane Oxygenation (ECMO) Systems market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Extracorporeal Membrane Oxygenation (ECMO) Systems manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Extracorporeal Membrane Oxygenation (ECMO) Systems Market Report

Report Metric Details
Report Name Extracorporeal Membrane Oxygenation (ECMO) Systems Market
Accounted market size in 2025 US$ 262 million
Forecasted market size in 2032 US$ 337 million
CAGR 3.7%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • VA (Veno-Arterial) ECMO
  • VV (Veno-Venous) ECMO
by Application
  • Neonatal
  • Pediatric
  • Adult
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, Getinge (Maquet), LivaNova (Sorin), Terumo, Fresenius Medical Care, Chinabridge(Shenzhen) Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Extracorporeal Membrane Oxygenation (ECMO) Systems manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Extracorporeal Membrane Oxygenation (ECMO) Systems sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Extracorporeal Membrane Oxygenation (ECMO) Systems Market growing?

Ans: The Extracorporeal Membrane Oxygenation (ECMO) Systems Market witnessing a CAGR of 3.7% during the forecast period 2026-2032.

What is the Extracorporeal Membrane Oxygenation (ECMO) Systems Market size in 2032?

Ans: The Extracorporeal Membrane Oxygenation (ECMO) Systems Market size in 2032 will be US$ 337 million.

Who are the main players in the Extracorporeal Membrane Oxygenation (ECMO) Systems Market report?

Ans: The main players in the Extracorporeal Membrane Oxygenation (ECMO) Systems Market are Medtronic, Getinge (Maquet), LivaNova (Sorin), Terumo, Fresenius Medical Care, Chinabridge(Shenzhen) Medical

What are the Application segmentation covered in the Extracorporeal Membrane Oxygenation (ECMO) Systems Market report?

Ans: The Applications covered in the Extracorporeal Membrane Oxygenation (ECMO) Systems Market report are Neonatal, Pediatric, Adult

What are the Type segmentation covered in the Extracorporeal Membrane Oxygenation (ECMO) Systems Market report?

Ans: The Types covered in the Extracorporeal Membrane Oxygenation (ECMO) Systems Market report are VA (Veno-Arterial) ECMO, VV (Veno-Venous) ECMO

1 Extracorporeal Membrane Oxygenation (ECMO) Systems Market Overview
1.1 Product Definition
1.2 Extracorporeal Membrane Oxygenation (ECMO) Systems by Type
1.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Value by Type: 2025 vs 2032
1.2.2 VA (Veno-Arterial) ECMO
1.2.3 VV (Veno-Venous) ECMO
1.3 Extracorporeal Membrane Oxygenation (ECMO) Systems by Application
1.3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Value by Application: 2025 vs 2032
1.3.2 Neonatal
1.3.3 Pediatric
1.3.4 Adult
1.4 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size Estimates and Forecasts
1.4.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue 2021–2032
1.4.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales 2021–2032
1.4.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Extracorporeal Membrane Oxygenation (ECMO) Systems Market Competition by Manufacturers
2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Manufacturers (2021–2026)
2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Extracorporeal Membrane Oxygenation (ECMO) Systems, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Extracorporeal Membrane Oxygenation (ECMO) Systems, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Extracorporeal Membrane Oxygenation (ECMO) Systems, Product Types and Applications
2.7 Global Key Manufacturers of Extracorporeal Membrane Oxygenation (ECMO) Systems, Date of Entry into the Industry
2.8 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Competitive Situation and Trends
2.8.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Players Market Share by Revenue
2.8.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Scenario by Region
3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region: 2021–2032
3.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region: 2021–2026
3.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region: 2027–2032
3.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region: 2021–2032
3.3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region: 2021–2026
3.3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region: 2027–2032
3.4 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Market Facts & Figures by Country
3.4.1 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021–2032)
3.4.3 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Market Facts & Figures by Country
3.5.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021–2032)
3.5.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Market Facts & Figures by Region
3.6.1 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (2021–2032)
3.6.3 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Extracorporeal Membrane Oxygenation (ECMO) Systems Market Facts & Figures by Country
3.7.1 Latin America Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021–2032)
3.7.3 Latin America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021–2032)
3.8.3 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Type (2021–2032)
4.1.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Type (2021–2026)
4.1.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Type (2027–2032)
4.1.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Type (2021–2032)
4.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Type (2021–2032)
4.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Type (2021–2026)
4.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Type (2027–2032)
4.2.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Type (2021–2032)
4.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Price by Type (2021–2032)
5 Segment by Application
5.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Application (2021–2032)
5.1.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Application (2021–2026)
5.1.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Application (2027–2032)
5.1.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Application (2021–2032)
5.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Application (2021–2032)
5.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Application (2021–2026)
5.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Application (2027–2032)
5.2.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Application (2021–2032)
5.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Getinge (Maquet)
6.2.1 Getinge (Maquet) Company Information
6.2.2 Getinge (Maquet) Description and Business Overview
6.2.3 Getinge (Maquet) Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Getinge (Maquet) Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
6.2.5 Getinge (Maquet) Recent Developments/Updates
6.3 LivaNova (Sorin)
6.3.1 LivaNova (Sorin) Company Information
6.3.2 LivaNova (Sorin) Description and Business Overview
6.3.3 LivaNova (Sorin) Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 LivaNova (Sorin) Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
6.3.5 LivaNova (Sorin) Recent Developments/Updates
6.4 Terumo
6.4.1 Terumo Company Information
6.4.2 Terumo Description and Business Overview
6.4.3 Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
6.4.5 Terumo Recent Developments/Updates
6.5 Fresenius Medical Care
6.5.1 Fresenius Medical Care Company Information
6.5.2 Fresenius Medical Care Description and Business Overview
6.5.3 Fresenius Medical Care Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fresenius Medical Care Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
6.5.5 Fresenius Medical Care Recent Developments/Updates
6.6 Chinabridge(Shenzhen) Medical
6.6.1 Chinabridge(Shenzhen) Medical Company Information
6.6.2 Chinabridge(Shenzhen) Medical Description and Business Overview
6.6.3 Chinabridge(Shenzhen) Medical Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Chinabridge(Shenzhen) Medical Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
6.6.5 Chinabridge(Shenzhen) Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Chain Analysis
7.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Extracorporeal Membrane Oxygenation (ECMO) Systems Production Mode & Process Analysis
7.4 Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Marketing
7.4.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Channels
7.4.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Distributors
7.5 Extracorporeal Membrane Oxygenation (ECMO) Systems Customer Analysis
8 Extracorporeal Membrane Oxygenation (ECMO) Systems Market Dynamics
8.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Trends
8.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Market Drivers
8.3 Extracorporeal Membrane Oxygenation (ECMO) Systems Market Challenges
8.4 Extracorporeal Membrane Oxygenation (ECMO) Systems Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units) of Key Manufacturers (2021–2026)
 Table 5. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Extracorporeal Membrane Oxygenation (ECMO) Systems Average Price (K US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Extracorporeal Membrane Oxygenation (ECMO) Systems, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Extracorporeal Membrane Oxygenation (ECMO) Systems, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Extracorporeal Membrane Oxygenation (ECMO) Systems, Product Types and Applications
 Table 12. Global Key Manufacturers of Extracorporeal Membrane Oxygenation (ECMO) Systems, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Companies by Tier (Tier 1, Tier 2, Tier 3), based on Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (Units), 2021–2026
 Table 18. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Region (2021–2026)
 Table 19. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (Units), 2027–2032
 Table 20. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Region (2027–2032)
 Table 21. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Region (2021–2026)
 Table 23. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Region (2027–2032)
 Table 25. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (Units), 2021–2026
 Table 27. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (Units), 2027–2032
 Table 28. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (Units), 2021–2026
 Table 32. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (Units), 2027–2032
 Table 33. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (Units), 2021–2026
 Table 37. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (Units), 2027–2032
 Table 38. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (Units), 2021–2026
 Table 42. Latin America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (Units), 2027–2032
 Table 43. Latin America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (Units), 2021–2026
 Table 47. Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (Units), 2027–2032
 Table 48. Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units) by Type (2021–2026)
 Table 51. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units) by Type (2027–2032)
 Table 52. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Type (2021–2026)
 Table 53. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Type (2027–2032)
 Table 54. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Type (2021–2026)
 Table 57. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Type (2027–2032)
 Table 58. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Price (K US$/Unit) by Type (2021–2026)
 Table 59. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Price (K US$/Unit) by Type (2027–2032)
 Table 60. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units) by Application (2021–2026)
 Table 61. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units) by Application (2027–2032)
 Table 62. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Application (2021–2026)
 Table 63. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Application (2027–2032)
 Table 64. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Application (2021–2026)
 Table 67. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Application (2027–2032)
 Table 68. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Price (K US$/Unit) by Application (2021–2026)
 Table 69. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Price (K US$/Unit) by Application (2027–2032)
 Table 70. Medtronic Company Information
 Table 71. Medtronic Description and Business Overview
 Table 72. Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 73. Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Product
 Table 74. Medtronic Recent Developments/Updates
 Table 75. Getinge (Maquet) Company Information
 Table 76. Getinge (Maquet) Description and Business Overview
 Table 77. Getinge (Maquet) Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 78. Getinge (Maquet) Extracorporeal Membrane Oxygenation (ECMO) Systems Product
 Table 79. Getinge (Maquet) Recent Developments/Updates
 Table 80. LivaNova (Sorin) Company Information
 Table 81. LivaNova (Sorin) Description and Business Overview
 Table 82. LivaNova (Sorin) Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 83. LivaNova (Sorin) Extracorporeal Membrane Oxygenation (ECMO) Systems Product
 Table 84. LivaNova (Sorin) Recent Developments/Updates
 Table 85. Terumo Company Information
 Table 86. Terumo Description and Business Overview
 Table 87. Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 88. Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Product
 Table 89. Terumo Recent Developments/Updates
 Table 90. Fresenius Medical Care Company Information
 Table 91. Fresenius Medical Care Description and Business Overview
 Table 92. Fresenius Medical Care Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 93. Fresenius Medical Care Extracorporeal Membrane Oxygenation (ECMO) Systems Product
 Table 94. Fresenius Medical Care Recent Developments/Updates
 Table 95. Chinabridge(Shenzhen) Medical Company Information
 Table 96. Chinabridge(Shenzhen) Medical Description and Business Overview
 Table 97. Chinabridge(Shenzhen) Medical Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 98. Chinabridge(Shenzhen) Medical Extracorporeal Membrane Oxygenation (ECMO) Systems Product
 Table 99. Chinabridge(Shenzhen) Medical Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Extracorporeal Membrane Oxygenation (ECMO) Systems Distributors List
 Table 103. Extracorporeal Membrane Oxygenation (ECMO) Systems Customers List
 Table 104. Extracorporeal Membrane Oxygenation (ECMO) Systems Market Trends
 Table 105. Extracorporeal Membrane Oxygenation (ECMO) Systems Market Drivers
 Table 106. Extracorporeal Membrane Oxygenation (ECMO) Systems Market Challenges
 Table 107. Extracorporeal Membrane Oxygenation (ECMO) Systems Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Extracorporeal Membrane Oxygenation (ECMO) Systems
 Figure 2. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Share by Type: 2025 & 2032
 Figure 4. VA (Veno-Arterial) ECMO Product Picture
 Figure 5. VV (Veno-Venous) ECMO Product Picture
 Figure 6. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Share by Application: 2025 & 2032
 Figure 8. Neonatal
 Figure 9. Pediatric
 Figure 10. Adult
 Figure 11. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size (US$ Million), 2021–2032
 Figure 13. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), 2021–2032
 Figure 14. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Average Price (K US$/Unit), 2021–2032
 Figure 15. Extracorporeal Membrane Oxygenation (ECMO) Systems Report Years Considered
 Figure 16. Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Share by Manufacturers in 2025
 Figure 17. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Players: Market Share by Revenue in Extracorporeal Membrane Oxygenation (ECMO) Systems in 2025
 Figure 19. Extracorporeal Membrane Oxygenation (ECMO) Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Country (2021–2032)
 Figure 22. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Country (2021–2032)
 Figure 26. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Region (2021–2032)
 Figure 34. China Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Taiwan Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Philippines Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. U.A.E Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Extracorporeal Membrane Oxygenation (ECMO) Systems by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Extracorporeal Membrane Oxygenation (ECMO) Systems by Type (2021–2032)
 Figure 56. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Price (K US$/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Extracorporeal Membrane Oxygenation (ECMO) Systems by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Extracorporeal Membrane Oxygenation (ECMO) Systems by Application (2021–2032)
 Figure 59. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Price (K US$/Unit) by Application (2021–2032)
 Figure 60. Extracorporeal Membrane Oxygenation (ECMO) Systems Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS